Prevalence of anemia in skilled-nursing home residents

被引:55
作者
Artz, AS
Fergusson, D
Drinka, PJ
Gerald, M
Gravenstein, S
Lechich, A
Silverstone, F
Finnigan, S
Janowski, MC
McCamish, MA
Ershler, WB
机构
[1] Inst Adv Studies Aging & Geriatr Med, Washington, DC 20007 USA
[2] NGRC, Washington, DC 20007 USA
[3] Univ Chicago, Ctr Med, Chicago, IL 60637 USA
[4] Ottawa Hosp, Inst Res, Ottawa, ON K1H 8L6, Canada
[5] Wisconsin Vet Home, King, WI 54946 USA
[6] Washington Nursing Facil, Washington, DC 20001 USA
[7] Eastern Virginia Med Sch, Norfolk, VA 23507 USA
[8] Ctr Terence Cardinal Cooke, Hlth Care Ctr, New York, NY 10029 USA
[9] Parker Jewish Inst Hlth Care & Rehabil, New Hyde Pk, NY 11040 USA
[10] Perlegan Sci Inc, Mountain View, CA 94043 USA
关键词
anemia; frail elderly; erythropoietin; nursing-home;
D O I
10.1016/j.archger.2004.03.006
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Anemia is a frequent problem among older persons, the prevalence of which may be particularly high in skilled-nursing facilities but recent data in this regard is lacking. The purpose of this study was to define the prevalence of anemia and its association with hospitalization in skilled-nursing home residents. We retrospectively reviewed randomly selected charts among five skilled-nursing facilities within the National Geriatrics Research Consortium (NGRC). Among 900 chronically residing patients with completed chart information, the mean and median ages were 79 years and 82 years, respectively. Eighty-seven percent of patients were 65 years or greater. Applying the World Health Organization criteria for anemia (hemoglobin < 12 g/dl for women and hemoglobin < 13 g/dl for men), we found a 6-month point prevalence of 48%. The hospitalization rate was higher among those with more severe anemia. Few residents were treated with recombinant erythropoietin therapy or red blood cell transfusion. Anemia is very common in the nursing home, and despite being associated with increased morbidity; it is, for the most part, untreated in this setting. With an increased understanding of erythropoiesis and the availability of recombinant growth factors, future studies should evaluate the causes and potential benefits of treatment in terms of quality of life, reduced morbidity and health economics. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 17 条
[1]   Incidence of anemia in older people: An epidemiologic study in a well defined population [J].
Ania, BJ ;
Suman, VJ ;
Fairbanks, VF ;
Rademacher, DM ;
Melton, LJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (07) :825-831
[2]  
Barclay DV, 1996, ARCH LATINOAM NUTR, V46, P122
[3]  
Blanc B., 1968, WHO TECH REP SER, V405, P5
[4]  
CARO J, 2000, IS ANEMIA INDEPENDEN
[5]  
CHAVES PH, 2001, CHALLENGING WHO CRIT
[6]  
CHEN LH, 1989, INT J VITAM NUTR RES, V59, P207
[7]  
Collins AJ, 2000, SEMIN NEPHROL, V20, P345
[8]  
DALY MP, 1989, J FAM PRACTICE, V28, P524
[9]   The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease [J].
Foley, RN ;
Parfrey, PS ;
Harnett, JD ;
Kent, GM ;
Murray, DC ;
Barre, PE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :53-61
[10]   IRON STATUS AND ANEMIA IN THE ELDERLY - NEW FINDINGS AND A REVIEW OF PREVIOUS STUDIES [J].
GARRY, PJ ;
GOODWIN, JS ;
HUNT, WC .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1983, 31 (07) :389-399